Medicalsystem Biotechnology (300439.SZ) obtained two medical device registration certificates.
Meikang Biotechnology (300439.SZ) announced that the company recently obtained the "Medical Device Registration Certificate (In vitro diagnostic reagent)" issued by the National Medical Products Administration and Zhejiang Provincial Medical Products Administration, including: Hepatitis B virus e antibody detection reagent kit (Chemiluminescent microparticle immunoassay), Golgi protein 73 detection reagent kit (Chemiluminescent microparticle immunoassay).
Medicalsystem Biotechnology (300439.SZ) announced that the company has recently obtained the "Medical Device Registration Certificate (In Vitro Diagnostic Reagents)" issued by the National Medical Products Administration and the Zhejiang Provincial Medical Products Administration, which includes: Hepatitis B virus e-antibody detection kit (Chemiluminescence Microparticle Immunoassay) and Golgi body protein 73 detection kit (Chemiluminescence Microparticle Immunoassay).
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
